Posted by 
Congratulations to Siemens Healthineers with the SOMATOM X.cite with myExam Companion on receiving AHRA’s 2020 Innovation Award!
Each year, the field of medical imaging lies at the forefront of healthcare advancement. Industry leaders pursue and develop new products and services that enable the growth of the field.
To highlight the latest and greatest additions to the market, AHRA hosted the second annual Innovation Showcase and Innovation Award for Annual Meeting attendees and AHRA members.
Viewers had the opportunity to learn about 18 featured products/services, then vote on the submission that best embodies innovation.
AHRA is pleased to honor Siemens Healthineers with the 2020 Innovation Award for SOMATOM X.cite with myExam Companion.
Congratulations to Siemens Healthineers and all featured who have demonstrated innovation and advancement in the field of medical imaging!
SOMATOM X.cite with myExam Companion, launches the era of intelligent imaging. Now technologists of any experience level can unlock the system’s groundbreaking potential. myExam Companion transforms real-time patient characterization – and the way staff operate the CT. myExam Companion guides them through any procedure, automatically adjusting key parameters to individual patients. The scanner also has a patient-friendly, 82 cm bore and the Vectron™ X-ray tube – for unprecedented power and resolution. This makes it uniquely equipped to improve personalization, no matter how challenging the patient or throughput is. From routine exams to advanced quantitative and functional procedures, SOMATOM X.cite empowers excellence in radiology and welcomes in the era of intelligent imaging.
About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion.
Further information is available at http://www.siemens-healthineers.com.
LINK 